Arbutus Biopharma (ABUS) Shares Outstanding (2010 - 2026)

Arbutus Biopharma has disclosed Shares Outstanding across 17 years of filings, most recently posting $196.9 million for Q1 2026.

• Shares Outstanding for Q1 2026 came in at $196.9 million, up 2.85% year-over-year; the trailing twelve-month figure through Mar 2026 was $196.9 million (up 2.85% YoY), and the FY2025 annual result was $192.5 million, up 1.35% from the prior year.
• Shares Outstanding came in at $196.9 million for Q1 2026 at Arbutus Biopharma, up from $192.5 million in the prior quarter.
• In the past five years, Shares Outstanding ranged from a high of $196.9 million in Q1 2026 to a low of $148.7 million in Q1 2022.
• The 5-year median for Shares Outstanding is $180.2 million (2024), against an average of $175.9 million.
• Across the five-year window, Shares Outstanding soared 12677.34% in 2022 and increased 1.33% in 2025, its largest moves.
• Arbutus Biopharma's Shares Outstanding stood at $157.5 million in 2022, then advanced by 7.88% to $169.9 million in 2023, then increased by 11.83% to $190.0 million in 2024, then climbed by 1.35% to $192.5 million in 2025, then gained by 2.29% to $196.9 million in 2026.
• The last three Shares Outstanding figures came in at $196.9 million (Q1 2026), $192.5 million (Q4 2025), and $192.0 million (Q3 2025), per Business Quant data.